In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Significance of exertional oscillatory ventilation in patients with chronic heart failure and comorbid chronic obstructive pulmonary disease

Session Poster session 1 Saturday 08:30 -17:30

Speaker Ewa Straburzynska-Migaj

Congress : Heart Failure 2015

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure
  • Session type : Poster Session
  • FP Number : P257

Authors : M Kaluzna-Oleksy (Poznan,PL), J Migaj (Poznan,PL), K Jemielity (Poznan,PL), K Pawelczyk (Poznan,PL), E Straburzynska-Migaj (Poznan,PL)

15 views

Authors:
M Kaluzna-Oleksy1 , J Migaj1 , K Jemielity2 , K Pawelczyk2 , E Straburzynska-Migaj1 , 1Poznan University of Medical Sciences, Ist Department of Cardiology - Poznan - Poland , 2Poznan University of Medical Sciences - Poznan - Poland ,

Citation:
European Journal of Heart Failure Abstracts Supplement ( 2015 ) 17 ( Supplement 1 ), 54

Introduction: Exertional oscillatory ventilation (EOV) occurs in many patients with chronic heart failure (CHF) and is a predictor of adverse outcomes in this population. Many CHF patients (20-40%) have also chronic obstructive pulmonary disease (COPD) which frequently delays diagnosis of CHF and complicates assessment of prognosis. The pathogenetic mechanism of EOV is still not clear; however, the breathing pattern of EOV is similar to central sleep apnoea. It is hypothesized that EOV is primarily related to impaired ability to augment cardiac index during exercise with secondary circulatory delay causing instability in the feedback loop of ventilatory control.

Aim: We aimed to estimate prevalence of EOV and its clinical significance in patients with CHF and comorbid COPD.

Material and Methods: It is a prospective analysis of 69 CHF patients (47 with CHF alone and 22 with both CHF and COPD). These patients underwent a symptom-limited treadmill exercise test with metabolic gas exchange measurements using RAMP protocol. EOV was defined by Corrá criteria as cyclic fluctuations in ventilation during over 60% of exercise, and with amplitude over 15% of the average amplitude at rest.

Results: Twenty-two patients with both CHF and COPD presented with similar age and NYHA class, and higher ejection fraction (EF) in comparison with those with CHF only. Cardiopulmonary exercise tests showed significantly lower breathing reserve (BR) and higher PETCO2 in the group with COPD. EOV occurred in 23.2 % of all the patients. Prevalence of EOV in both groups did not differ significantly (p = 0.807). A 3-month follow-up showed no significant differences in mortality and hospitalization rates between the patients with CHF only and those with comorbid COPD.

Conclusion: COPD does not influence occurrence of EOV in patients with CHF. Further studies are required to evaluate if EOV has the same prognostic value in patients with CHF regardless of pulmonary diseases.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are